Table 3.
Medical and Inpatient/Emergency Department Unadjusted Costs: On-Treatment Analysis
| Medication-specific costs | Inpatient and emergency department costs, mean, $ (± SD) | Medical costs (outpatient + inpatient), mean, $ (± SD) |
|---|---|---|
| All-cause costs | ||
| Aripiprazole | 299 (± 2087) | 804 (± 2523) |
| Olanzapine | 443 (± 3106) | 1038 (± 3771) |
| Quetiapine | 468 (± 2614) | 1089 (± 3450) |
| Risperidone | 453 (± 2598) | 1032 (± 3103) |
| Ziprasidone | 588 (± 2552) | 1151 (± 2928) |
| Mental health–related costs | ||
| Aripiprazole | 225 (± 1893) | 475 (± 2145) |
| Olanzapine | 301 (± 2024) | 621 (± 2382) |
| Quetiapine | 331 (± 2102) | 655 (± 2479) |
| Risperidone | 318 (± 2062) | 674 (± 2453) |
| Ziprasidone | 415 (± 2015) | 711 (± 2263) |
Costs reported as per treated patient per month in 2008 US dollars. SD indicates standard deviation.